Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2021

Open Access 01-12-2021 | Metastasis | Case report

Submandibular lymph node metastasis of occult thyroid carcinoma first suspected to be a salivary gland tumor: a case report

Authors: Hiroyuki Kaneko, Mami Deguchi, Hisashi Yano

Published in: Journal of Medical Case Reports | Issue 1/2021

Login to get access

Abstract

Background

When diagnosing and treating neck masses, various diseases need to be considered, including benign or malignant tumors, lymph node-related diseases, and cysts. Thus, there may be cases in which making a definitive diagnosis is difficult on the basis of blood testing and imaging alone.

Case presentation

The patient was an 80-year-old Japanese female who presented with swelling in the right submandibular area. Magnetic resonance imaging and ultrasonography revealed a solid tumor with inhomogeneous content continuous with the submandibular gland. Therefore, the clinical diagnosis was salivary gland tumor. Surgical treatment was performed, and intraoperative frozen-section examination demonstrated submandibular lymph node metastasis of thyroid carcinoma. After surgical treatment, blood test for thyroid gland function yielded normal results except for increased thyroglobulin levels. Further positron-emission tomography–computed tomography and ultrasonography were performed, in addition to fine-needle aspiration biopsy of the thyroid gland and other tests; however, no other thyroid abnormalities were observed. Fine-needle aspiration biopsy revealed no carcinomatous components. Close observational follow-up has been continued without thyroid gland treatment, and as of approximately 8 years postoperation, no recurrence, metastases, or thyroid carcinoma have developed.

Conclusion

The mass was lymph node metastasis of occult thyroid carcinoma. In general, occult thyroid carcinoma metastasizes to level II–V. To the best of our knowledge, this is the first report of submandibular lymph node metastasis alone of occult thyroid carcinoma.
Literature
1.
go back to reference Kwee TC, Kwee RM. Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis. Eur Radiol. 2009;19:731–4.CrossRef Kwee TC, Kwee RM. Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis. Eur Radiol. 2009;19:731–4.CrossRef
2.
go back to reference Gnepp DR. Cyst of the neck, unknown primary tumor and neck dissection. Diagnostic surgical pathology of the head and neck. Sounders NY. 2001; pp. 650–80. Gnepp DR. Cyst of the neck, unknown primary tumor and neck dissection. Diagnostic surgical pathology of the head and neck. Sounders NY. 2001; pp. 650–80.
3.
go back to reference Zhuang SN, Wu XF, Li JJ, Zhang GH. Management of lymph node metastases from an unknown primary site to the head and neck. Mol Clin Oncol. 2014;2:917–22.CrossRef Zhuang SN, Wu XF, Li JJ, Zhang GH. Management of lymph node metastases from an unknown primary site to the head and neck. Mol Clin Oncol. 2014;2:917–22.CrossRef
4.
go back to reference Majchrzak E, Cholewinski W, Golusinski W. Carcinoma of unknown primary in the head and neck: the evaluation of the effectiveness of 18F-FDG-PET/CT, own experience. Rep Pract Oncol Radiother. 2015;20:393–7.CrossRef Majchrzak E, Cholewinski W, Golusinski W. Carcinoma of unknown primary in the head and neck: the evaluation of the effectiveness of 18F-FDG-PET/CT, own experience. Rep Pract Oncol Radiother. 2015;20:393–7.CrossRef
5.
go back to reference Ansari-Lari MA, Westra WH. The prevalence and significance of clinically unsuspected neoplasms in cervical lymph nodes. Head Neck. 2003;25(10):841–7.CrossRef Ansari-Lari MA, Westra WH. The prevalence and significance of clinically unsuspected neoplasms in cervical lymph nodes. Head Neck. 2003;25(10):841–7.CrossRef
6.
go back to reference Pusztaszeri MP, Faquin WC. Cytologic evaluation of cervical lymph node metastases from cancers of unknown primary origin. Semin Diagn Pathol. 2015;32(1):32–41.CrossRef Pusztaszeri MP, Faquin WC. Cytologic evaluation of cervical lymph node metastases from cancers of unknown primary origin. Semin Diagn Pathol. 2015;32(1):32–41.CrossRef
7.
go back to reference Cunha N, Rodrigues F, Curado F, Ilheu O, Cruz C, Naidenov P, Rascao MJ, Ganho J, Gomes I, Pereora H, Real O, Figueiredo P, Campos B, Valido F. Thyroglobulin detection in fine-needle aspirates of cervical lymph nodes: a technique for the diagnosis of metastatic differentiated thyroid cancer. Eur J Endocrinol. 2007;157:101–7.CrossRef Cunha N, Rodrigues F, Curado F, Ilheu O, Cruz C, Naidenov P, Rascao MJ, Ganho J, Gomes I, Pereora H, Real O, Figueiredo P, Campos B, Valido F. Thyroglobulin detection in fine-needle aspirates of cervical lymph nodes: a technique for the diagnosis of metastatic differentiated thyroid cancer. Eur J Endocrinol. 2007;157:101–7.CrossRef
8.
go back to reference Chen YH, Yang XM, Li SS, Wang YH, He JJ, Yang YD, Wang S, Liu JJ, Zhang XL. Value of fused positron emission tomography CT in detecting primaries in patients with primary unknown cervical lymph node metastasis. J Med Imaging Radiat Oncol. 2012;56:66–74.CrossRef Chen YH, Yang XM, Li SS, Wang YH, He JJ, Yang YD, Wang S, Liu JJ, Zhang XL. Value of fused positron emission tomography CT in detecting primaries in patients with primary unknown cervical lymph node metastasis. J Med Imaging Radiat Oncol. 2012;56:66–74.CrossRef
9.
go back to reference Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SK, Kim SK. Utility of combined 18F-fluorodeoxyglucose-positoron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Oral Oncol. 2009;45:218–24. Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SK, Kim SK. Utility of combined 18F-fluorodeoxyglucose-positoron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Oral Oncol. 2009;45:218–24.
10.
go back to reference Feine U, Lietzenmayer R, Hanke JP, Held J, Wöhrle H, Müller-Schauenburg W. Fluorine-18-FDG and iodine-131-iodine uptake in thyroid cancer. J Nucl Med. 1996;37:1468–72.PubMed Feine U, Lietzenmayer R, Hanke JP, Held J, Wöhrle H, Müller-Schauenburg W. Fluorine-18-FDG and iodine-131-iodine uptake in thyroid cancer. J Nucl Med. 1996;37:1468–72.PubMed
11.
go back to reference Guenzel T, Franzen A, Wiegand S, Kraetschmer S, Ludwig J, Mironczuk R, Wilhelm T, Schrom T. The value of PET compared MRI in malignant head and neck tumors. Anticancer Res. 2013;33:1141–6.PubMed Guenzel T, Franzen A, Wiegand S, Kraetschmer S, Ludwig J, Mironczuk R, Wilhelm T, Schrom T. The value of PET compared MRI in malignant head and neck tumors. Anticancer Res. 2013;33:1141–6.PubMed
12.
go back to reference Dietlein M, Scheidhauer K, Voth E, Theissen P, Schicha H. Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-1311 whole-body scintigraphy in the follow-up of differentiated thyroid cancer. Euro J Nucl Med. 1997;24:1342–8.CrossRef Dietlein M, Scheidhauer K, Voth E, Theissen P, Schicha H. Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-1311 whole-body scintigraphy in the follow-up of differentiated thyroid cancer. Euro J Nucl Med. 1997;24:1342–8.CrossRef
13.
go back to reference Ito Y, Hirokawa M, Fukushima M, Inoue H, Yabuta T, Uruno T, Kihara M, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyauchi A. Occult papillary thyroid carcinoma: diagnostic and clinical implications in the era of routine ultrasonography. World J Surg. 2008;32:1955–60.CrossRef Ito Y, Hirokawa M, Fukushima M, Inoue H, Yabuta T, Uruno T, Kihara M, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyauchi A. Occult papillary thyroid carcinoma: diagnostic and clinical implications in the era of routine ultrasonography. World J Surg. 2008;32:1955–60.CrossRef
14.
go back to reference Alecu L, Barbulescu M, Ursut B, Enciu O, Slavu I, Braga V. Occult thyroid carcinoma in our experience—should we reconsider total thyroidectomy for benign thyroid pathology? Chirugia. 2014;109(2):191–7. Alecu L, Barbulescu M, Ursut B, Enciu O, Slavu I, Braga V. Occult thyroid carcinoma in our experience—should we reconsider total thyroidectomy for benign thyroid pathology? Chirugia. 2014;109(2):191–7.
15.
go back to reference Boucek J, Kastner J, Skrivan J, Grosso E, Gibelli B, Giugliano G, Betka J. Occult thyroid carcinoma. Acta Otorhinolaryngol Ital. 2009;29:296–304.PubMedPubMedCentral Boucek J, Kastner J, Skrivan J, Grosso E, Gibelli B, Giugliano G, Betka J. Occult thyroid carcinoma. Acta Otorhinolaryngol Ital. 2009;29:296–304.PubMedPubMedCentral
16.
go back to reference Kr A, Sebastian P, Somanathan T, George NA, Jayasree K. Significance of incidentally detected thyroid tissue in lymph nodes of neck dissections in patients with head and neck carcinoma. Int J Surg Pathol. 2012;20(6):564–9.CrossRef Kr A, Sebastian P, Somanathan T, George NA, Jayasree K. Significance of incidentally detected thyroid tissue in lymph nodes of neck dissections in patients with head and neck carcinoma. Int J Surg Pathol. 2012;20(6):564–9.CrossRef
17.
go back to reference Keum HS, Ji YB, Kim JM, Choi WH, Ahn YH, Tae K. Optimal surgical extent of lateral and central neck dissection for papillary carcinoma located in one lobe with clinical lateral lymph node metastasis. World J Surg Oncol. 2012;10:221–6.CrossRef Keum HS, Ji YB, Kim JM, Choi WH, Ahn YH, Tae K. Optimal surgical extent of lateral and central neck dissection for papillary carcinoma located in one lobe with clinical lateral lymph node metastasis. World J Surg Oncol. 2012;10:221–6.CrossRef
Metadata
Title
Submandibular lymph node metastasis of occult thyroid carcinoma first suspected to be a salivary gland tumor: a case report
Authors
Hiroyuki Kaneko
Mami Deguchi
Hisashi Yano
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2021
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-021-02901-7

Other articles of this Issue 1/2021

Journal of Medical Case Reports 1/2021 Go to the issue